HASHIMOTO’S THYROIDITIS WITH SYSTEMIC INVOLVEMENT
A CASE REPORT
Keywords:
HASHIMOTO’S THYROIDITIS, antibody-mediated, hypothyroidismAbstract
INTRODUCTION/BACKGROUND
Hashimoto’s thyroiditis is the most common cause of acquired primary hypothyroidism in children. It is an autoimmune disease involving cell and antibody-mediated immune processes, leading to progressive fibrosis. Severe hypothyroidism may have variable clinical manifestation mimicking other multiorgan dysfunction.
CASE
We report an 8-year-old male who presented to our centre with a 4-month history of intermittent facial and lower limb swelling associated with unintentional weight gain, cold intolerance, easy fatigability, and regression in school performance. There was no family history of thyroid disease or autoimmune disorder. He visited the healthcare clinic 2 weeks prior to presentation for an upper respiratory tract infection however hypothyroid symptoms were not addressed. He was a short male with weight of 29.7 kg (75th centile) and height of 119 cm (10th centile) with evidence of faltering growth and coarse facies. He has a diffuse goitre measuring 8 x 3 cm (length x width) associated with thyroid acropachy, bilateral pretibial myxoedema and bradyarrhythmia (mean heart rate 56/ min). His biochemical results showed a markedly elevated TSH 2233 mIU/L with FT4 2pmol/L, anti TPO >1000 IU/ml
and anti-TG antibody 53.7 IU/ml. He was started with oral levothyroxine 25 mcg daily (0.8 mcg/kg/day) and the dose was titrated up slowly to 50 mcg daily (1.7 mcg/kg/day) over 4 weeks. He received one stress dose of intravenous hydrocortisone 100 mg (100 mg/m2/dose) on the day of admission due to hypotension upon starting thyroxine. His status of adrenal insufficiency has not been ruled out. There were no other complications of myxoedema coma.
CONCLUSION
We report a case of missed hypothyroidism despite frank symptoms and signs. This was the highest TSH reported in our centre and likely in Malaysia. Prolonged untreated Hashimoto’s thyroiditis is associated with high morbidity and mortality risk. Initiating treatment must be done cautiously to prevent crisis and complications.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jia Jian Tang, Qiao Yun Lee, Nur Syafiqah Hamizi, Nurshadia Samingan, Azriyanti Anuar Zaini, Muhammad Yazid Jalaludin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.